Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Clinical trial NCT00101907 · TERMINATED

Trial details

NCT number: NCT00101907
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Pancreatic Cancer Esophageal Cancer

Start date: 2004-12-01
Primary completion: 2007-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.